Chugai Pharmaceutical stock at EUR 34.02, market value JPY 9.9 trillion

Published on 10/12/2026 at 13:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Chugai Pharmaceutical stock costs EUR 34.02 on October 12, 2026 versus EUR 33.52 in Frankfurt on October 9. Market value was JPY 9.9 trillion.

Key points in brief

Chugai Pharmaceutical stock was EUR 34.02 at Lang & Schwarz on October 12, 2026 at 1:21 p.m. CEST.
The company's market capitalization was JPY 9.9 trillion as of October 9, 2026.
The EUR 33.52 to EUR 56.26 52-week range places the current euro quote near its lower end.
Chugai's next fiscal year 2026 third-quarter results are scheduled for October 27, 2026.

Chugai Pharmaceutical, JP3519400000, Illustration mit AI erstellt.

Chugai Pharmaceutical stock was trading at EUR 34.02 at Lang & Schwarz on October 12, 2026 at 1:21 p.m. CEST, while the company's market capitalization stood at JPY 9.9 trillion as of October 9. The euro quote remains close to the lower end of the EUR 33.52 to EUR 56.26 52-week range recorded for the Frankfurt listing.

Bid and ask frame the quote

The Lang & Schwarz bid was EUR 33.77 and the ask was EUR 34.26 at the same October 12 snapshot. That spread of EUR 0.49 gives investors a direct measure of the difference between the displayed buying and selling prices.

Stock remains near its yearly low

Investing.com listed the Frankfurt quote at EUR 33.52 on October 9, 2026, with a 52-week high of EUR 56.26. The current EUR 34.02 price is 39.53 percent below that high, calculated in euros against the same quoted range.

On the Tokyo Stock Exchange, Chugai traded at JPY 6,019 on October 9, 2026, according to the finance market snapshot. That quote was down 1.44 percent in its home-market session, while the euro indication here is a separate Lang & Schwarz market view.

Valuation and analyst targets

The Tokyo listing carried a trailing P/E ratio of 21.01 and a dividend yield of 0.04 as of October 9, 2026. Its market capitalization was JPY 9.9 trillion on the same date.

Markets Insider reported on October 7, 2026 that Citi maintained a Buy rating and a JPY 11,100.00 price target. The target was 33.33 percent above the JPY 8,329.88 consensus target cited in the same report.

Comparison with peers

Chugai Pharmaceutical: , P/E 21.01, market capitalization JPY 9.9 trillion

Takeda Pharmaceutical (Tokyo, JPY): plus 0.46 percent, P/E 52.09, market capitalization JPY 9.3 trillion

Daiichi Sankyo (Tokyo, JPY): minus 1.15 percent, P/E 19.87, market capitalization JPY 4.8 trillion

Next results date is October 27

Chugai Pharmaceutical lists its fiscal year 2026 third-quarter results for October 27, 2026 at 5:00 p.m. JST. The release covers the January to September 2026 period and will provide the next scheduled operating update.

Euro quote stays the market anchor

The Lang & Schwarz price of EUR 34.02 on October 12, 2026 gives German investors a euro-based reference, while the Tokyo figures provide the home-market context. The current quote, valuation and scheduled results date create three separate markers for assessing the stock's next trading phase.

The further course of trading is shown by the continuously updated real-time quote of Chugai Pharmaceutical stock.